On Tuesday, December 30, 2025, the Drug Enforcement Administration (“DEA”) and the Division of Well being and Human Providers (“HHS,” and along with the DEA, the “Businesses”) issued a fourth short-term rule (the “Fourth Short-term Rule”) extending the COVID-19-era telemedicine flexibilities for prescribing Schedule II–V managed substances by way of December 31, 2026. The extension permits DEA-registered practitioners to proceed prescribing managed drugs by way of telemedicine with no prior in-person go to, topic to current safeguards and state legislation. The Fourth Short-term Rule notes that the Businesses proceed to work on everlasting laws, together with a particular telemedicine registration framework.
For extra data concerning the DEA and HHS proposed guidelines or different concerns associated to telehealth prescriptions, please contact:
Corridor Render weblog posts and articles are supposed for informational functions solely. For moral causes, Corridor Render attorneys can not—exterior of an attorney-client relationship—reply particular questions that may be authorized recommendation.